Cost-sharing for epilepsy-related prescription drugs and medical supplies limited.

HF 3652 adds epilepsy to Minnesota's list of chronic diseases that qualify for reduced cost-sharing on prescription drugs and medical supplies under health insurance plans. The bill amends existing law to define "chronic disease" as including diabetes, asthma, allergies requiring epinephrine, and now epilepsy. It ensures that cost-sharing (like co-pays and coinsurance) for epilepsy-related medications and supplies - such as seizure management drugs, medical devices, and related equipment - cannot exceed the same limits applied to other covered chronic conditions. This change would apply to health plans offered, issued, or renewed on or after January 1, 2027.